1. Home
  2. DSS vs EVGN Comparison

DSS vs EVGN Comparison

Compare DSS & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DSS Inc.

DSS

DSS Inc.

HOLD

Current Price

$0.91

Market Cap

9.2M

ML Signal

HOLD

Logo Evogene Ltd

EVGN

Evogene Ltd

HOLD

Current Price

$0.81

Market Cap

9.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSS
EVGN
Founded
1984
1999
Country
United States
Israel
Employees
N/A
N/A
Industry
Containers/Packaging
Agricultural Chemicals
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
9.1M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
DSS
EVGN
Price
$0.91
$0.81
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.50
AVG Volume (30 Days)
24.6K
122.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
42.45
N/A
EPS
N/A
N/A
Revenue
$2,085,000.00
N/A
Revenue This Year
$14.93
N/A
Revenue Next Year
N/A
$69.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$0.73
52 Week High
$1.90
$2.42

Technical Indicators

Market Signals
Indicator
DSS
EVGN
Relative Strength Index (RSI) 50.97 36.09
Support Level $0.91 N/A
Resistance Level $0.97 $1.23
Average True Range (ATR) 0.05 0.05
MACD 0.01 -0.00
Stochastic Oscillator 40.76 25.18

Price Performance

Historical Comparison
DSS
EVGN

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.

Share on Social Networks: